AstraZeneca-Merck’s Lynparza wins EU approval for pancreatic cancer
The approval was based on results from a late-stage trial in which Lynparza nearly doubled the lifespan of patients
AstraZeneca…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Merck & Co
FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer
The study demonstrated a statistically significant improvement in progression-free survival (PFS) as assessed by a blinded…
‘Ramadan, Diabetes & Me’ app tracks blood glucose levels and easily reports to healthcare…
MSD Pharmaceuticals (MSD India), a wholly-owned subsidiary of Merck & Co, Whitehouse Station, New Jersey, USA, has launched a…